# Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium.

> **NCT01260038** · — · COMPLETED · sponsor: **University Hospital, Antwerp** · enrollment: 107 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01260038
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2012-01-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01260038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01260038, "Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium.". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01260038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*